Cystatin C: a Marker of Renal Function Or Something More?(Editorials) Cystatin C: a Marker of Renal Function Or Something More?(Editorials)

Cystatin C: a Marker of Renal Function Or Something More?(Editorials‪)‬

Clinical Chemistry, 2005, Feb, 51, 2

    • €2.99
    • €2.99

Publisher Description

Over the past decade, we have come to appreciate that individuals with even moderately reduced renal function are at increased risk for cardiovascular morbidity and mortality. There is no consensus, however, on how renal function should be measured. The most precise and accurate methods (such as inulin clearance) are impractical in the clinical setting and for larger research studies. Serum creatinine has been the mainstay by which renal function has been estimated for decades, but it is crude and can often be misleading. Age, weight, sex, and race influence creatinine production and thus need to be taken into account when evaluating a serum creatinine value. For example, an elderly woman with a serum creatinine in the "normal" range can have severely reduced renal function. Although measurements of serum creatinine are relatively inexpensive and widely available, they do have limitations. In an attempt to address some of these limitations, equations have been derived to estimate either creatinine clearance or the glomerular filtration rate (GFR). The most commonly used equation for estimating creatinine clearance is the Cockcroft-Gault formula (1). GFR calculated by this equation correlates well with measured GFR when renal function is within the reference interval, but as renal function declines, it overestimates GFR because creatinine is removed not only by glomerular filtration by also by renal tubular secretion. When GFR is low, tubular secretion becomes an important factor. Another formula, the MDRD (Modification of Diet in Renal Disease) equation, is the most widely used to estimate GFR (2). It too has several limitations, including lack of validation within the reference interval, the susceptibility of the alkaline-picrate creatinine method to interferences, and the lack of harmonization of creatinine assays. The variation between laboratories for plasma creatinine may be 30% or more. This has serious implications when using an estimating equation that was derived with a different creatinine method (3).

GENRE
Science & Nature
RELEASED
2005
1 February
LANGUAGE
EN
English
LENGTH
9
Pages
PUBLISHER
American Association for Clinical Chemistry, Inc.
SIZE
162.4
KB

More Books Like This

Plasma Concentrations of Cystatin C in Patients with Coronary Heart Disease and Risk for Secondary Cardiovascular Events: More Than Simply a Marker of Glomerular Filtration Rate (Proteomics and Protein Markers) (Clinical Report) Plasma Concentrations of Cystatin C in Patients with Coronary Heart Disease and Risk for Secondary Cardiovascular Events: More Than Simply a Marker of Glomerular Filtration Rate (Proteomics and Protein Markers) (Clinical Report)
2005
Recent Developments in the Evaluation of Glomerular Filtration Rate: Is There a Place for [Beta]-Trace?(Editorials) Recent Developments in the Evaluation of Glomerular Filtration Rate: Is There a Place for [Beta]-Trace?(Editorials)
2005
Cystatin C is an Independent Predictor of Fasting and Post-Methionine Load Total Homocysteine Concentrations Among Stable Renal Transplant Recipients (Endocrinology and Metabolism) Cystatin C is an Independent Predictor of Fasting and Post-Methionine Load Total Homocysteine Concentrations Among Stable Renal Transplant Recipients (Endocrinology and Metabolism)
2001
Kidney Biomarkers (Enhanced Edition) Kidney Biomarkers (Enhanced Edition)
2020
Role of Biomarkers in Risk Stratification of Acute Coronary Syndrome (Report) Role of Biomarkers in Risk Stratification of Acute Coronary Syndrome (Report)
2010
Contemporary Practice in Clinical Chemistry Contemporary Practice in Clinical Chemistry
2020

More Books by Clinical Chemistry

Impact of the Third Cholesterol Report from the Adult Treatment Panel of the National Cholesterol Education Program on the Clinical Laboratory (Special Report) Impact of the Third Cholesterol Report from the Adult Treatment Panel of the National Cholesterol Education Program on the Clinical Laboratory (Special Report)
2002
DNA Methylation Changes in Sera of Women in Early Pregnancy are Similar to Those in Advanced Breast Cancer Patients (Technical Briefs) DNA Methylation Changes in Sera of Women in Early Pregnancy are Similar to Those in Advanced Breast Cancer Patients (Technical Briefs)
2004
Colorectal Carcinoma Susceptibility and Metastases are Associated with Matrix Metalloproteinase-7 Promoter Polymorphisms (Technical Briefs) Colorectal Carcinoma Susceptibility and Metastases are Associated with Matrix Metalloproteinase-7 Promoter Polymorphisms (Technical Briefs)
2003
High-Sensitivity C-Reactive Protein As a Predictor of All-Cause Mortality: Implications for Research and Patient Care (Editorial) High-Sensitivity C-Reactive Protein As a Predictor of All-Cause Mortality: Implications for Research and Patient Care (Editorial)
2008
Biological Variation of Tumor Markers and Its Application in the Detection of Disease Progression in Patients with Non-Small Cell Lung Cancer (Technical Briefs) Biological Variation of Tumor Markers and Its Application in the Detection of Disease Progression in Patients with Non-Small Cell Lung Cancer (Technical Briefs)
2005
D-Dimer Testing for Deep Venous Thrombosis: A Metaanalysis (Clinical Report) D-Dimer Testing for Deep Venous Thrombosis: A Metaanalysis (Clinical Report)
2004